Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

FDA Approved. | Image Credit: Nirusmee - stock.adobe.com .jpeg
Oxylanthanum Carbonate Fails to Secure FDA Approval for Hyperphosphatemia, CKD

June 30th 2025

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com
Smartphone-Powered CKD Screening Yields 2.5-Fold Increase in Testing, Early Diagnoses

June 27th 2025

Clinical trial researchers interact with data | Image Credit: elenabsl - stock.adobe.com .jpeg
Lorundrostat Yields Promising Results for Treatment of Hypertension in Patients with CKD and Albuminuria

June 20th 2025

Medicine doctor analysis and diagnosis checking health of patient online and testing result with modern virtual interface on laptop with stethoscope in hand, Online Medical global network - ipopba - stock.adobe.com.jpeg
Dual-Biomarker Approach Best for Equitable Kidney Disease Risk Assessment, New Data Find

June 11th 2025

Dialysis nurse | image credit istockphoto.com
Dialysis Outcomes Tied to Nephrologist Facility Quality, Widening Racial Inequities

May 30th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Robert Gabbay, MD, PhD
February 24th 2022

Dr Robert Gabbay Talks About Adding Finenerone as a Recommended Drug in New ADA Guidelines

Skylar Jeremias
Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), breaks down the reasoning behind the organization's decision to add Bayer's Kerendia (finerenon) as a recommended drug for kidney disease prevention.
Kidneys
February 23rd 2022

Clean Air Laws Linked With Improved Kidney Biomarkers, Study Finds

Julia Bonavitacola
A quasiexperimental study conducted in China provides strong evidence that air pollution is linked to kidney impairment, which points to the importance of policy efforts to ensure clean air.
Robert Gabbay, MD, PhD
February 17th 2022

Dr Robert Gabbay Discusses the Importance of New CKD Section in ADA Guidelines

Skylar Jeremias
Robert Gabbay, MD, PhD, of the American Diabetes Association, explains why a section on chronic kidney disease management was added to the ADA's 2022 standard of care guidelines.
Fresenius Medial Care logo
February 14th 2022

Fresenius Medical Care North America Partners With Nephrologists for Kidney Care Payment Models

Skylar Jeremias
The organization announced a partnership with over 1000 nephrology providers to help implement CMS’ new Kidney Care Choices models beginning this year.
doctor looking at screen showing a heart
February 10th 2022

Improving Models to Boost Prediction of CVD Issues in Patients With CKD

Skylar Jeremias
Adding risk factors specific to patients with chronic kidney disease (CKD) to risk prediction models for cardiovascular disease (CVD) could improve risk prediction capabilities for a population of patients often subject to invasive diagnostic procedures, investigators concluded.
doctor taking notes on a clipboard while a patient speaks
February 7th 2022

Which Factors Sway Patient, Caregiver Decisions About CKD Research Participation?

Skylar Jeremias
Patients with chronic kidney disease (CKD) and their caregivers who have participated in CKD research shared factors that may encourage or discourage others from enrolling in clinical studies, highlighting the ways that investigators can better involve patients in research.
kidneys
February 5th 2022

Poor Kidney Function Significantly Linked With Dementia Incidence

Gianna Melillo
Data from a 10-year follow-up study showed declining kidney function is significantly associated with dementia risk among older adults.
Robert A. Gabbay, MD, PhD
February 4th 2022

Dr Robert Gabbay Explains the Development of the ADA's New CKD Guidelines

Skylar Jeremias
Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), discusses the development process for the section of ADA guidelines that touches on chronic kidney disease (CKD) management in patients with diabetes.
pair of digitized kidneys
January 27th 2022

New Section on Chronic Kidney Disease Risk Management Added to ADA Standard of Care Guidelines

Skylar Jeremias
The American Diabetes Association (ADA) has added a new section to their 2022 Standard of Care guidelines to assist clinicians in managing and preventing the presence of chronic kidney disease and related complications in patients with diabetes.
doctor talking to a man and woman
January 24th 2022

Gender Differences for Health-Related QOL Detected Among Patients With Advanced Kidney Disease

Skylar Jeremias
Although men and women with advanced kidney disease experienced physical and mental declines in health-related quality of life (QOL), men’s declines occurred at a significantly faster rate, researchers concluded.
old man talking to a doctor
January 20th 2022

Study Reveals Concerns Over High Protein Intake in Elderly Patients With CKD

Skylar Jeremias
More nutritional care may be needed for elderly patients with chronic kidney disease (CKD) who are ingesting higher-than-recommended amounts of protein, investigators concluded.
man pointing at a hexagon that saying AI inside
January 19th 2022

Study: Which AI Model Is the Best at Detecting Early-Stage CKD?

Skylar Jeremias
A study comparing 4 different artificial intelligence (AI) models found that some models were better than others at detecting early-stage chronic kidney disease (CKD), when patients do not experience visible symptoms.
globe with a stethoscope positioned around it
January 11th 2022

Study: New Policies Are Needed to Address Global CKD Disparities

Skylar Jeremias
Investigators offered insight into disparities between countries regarding chronic kidney disease burden and suggestions on how those disparities can be addressed.
image of kidneys over a watercolor background of yellow and blue
January 9th 2022

Apixaban Cuts Recurrent Venous Thromboembolism Risk in CKD Better Than Warfarin

Skylar Jeremias
Risk of recurrent venous thromboembolism (VTE) in patients with chronic kidney disease (CKD) and VTE was significantly reduced in those who were treated with apixaban vs warfarin, investigators concluded.
a fat man
January 7th 2022

Review: Greater Focus on Targeting Insulin Resistance in Patients With CKD May Be Needed

Skylar Jeremias
Insulin resistance may become a future target of treatment in the chronic kidney disease (CKD) population because of the several mechanisms in patients that contribute to increasing resistance, authors of a review concluded.
man using a smartphone
December 30th 2021

Focus Group Expresses Needs, Wants for a Mobile CKD Management App

Skylar Jeremias
A focus group consisting of patients with chronic kidney disease (CKD) as well as CKD providers and researchers shared what they deem necessary and helpful to include in future mobile CKD management applications.
Top 5 Most-Read Chronic Kidney Disease Articles of 2021
December 23rd 2021

Top 5 Most-Read Chronic Kidney Disease Articles of 2021

Skylar Jeremias
The top 5 most-read chronic kidney disease stories of 2021 on AJMC.com significantly focused on aiding physicians with determining patient risk of developing the disease or experiencing renal complications.
model of a kidney over a complex red background
December 21st 2021

Study: Pulse Pressure Could Serve as Predictive Marker for CKD Progression

Skylar Jeremias
Pulse pressure was found to have a significant association with chronic kidney disease (CKD), indicating that changes in pulse pressure could serve as a predictive marker for disease progression.
woman with face in her hands looking sad
December 17th 2021

Dialysis Modality Influenced Degree of Pandemic-Related Psychological Distress in Patients With CKD

Skylar Jeremias
Patients with chronic kidney disease (CKD) undergoing hemodialysis experienced a greater degree of psychological distress during the COVID-19 pandemic compared with patients treated with peritoneal dialysis, investigators found.
diagram of kidneys over a blue and yellow watercolor background
December 13th 2021

Acute Kidney Injury Episodes Led to Significant Impacts on Physical, Emotional Health

Skylar Jeremias
Patients who have experienced acute kidney injury (AKI) reported experiencing significant impacts on aspects of their physical and emotional health, demonstrating the different ways that AKI episodes influence patients’ health-related quality of life.
Study: Heating Climate Can Lead to Higher Risks of Mortality, Hospitalization in Patients With ESRD
December 9th 2021

Study: Heating Climate Can Lead to Higher Risks of Mortality, Hospitalization in Patients With ESRD

Skylar Jeremias
Rising ambient temperatures were found to be associated with higher risks of all-cause mortality and all-cause hospitalization in patients with end-stage renal disease (ESRD), highlighting the some of the health-related consequences of climate change.
Site Logo
December 8th 2021

Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone - Participating Faculty

Site Logo
December 8th 2021

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

Linda F. Fried, MD, MPH Natalia Petruski-Ivleva, PhD Kerstin Folkerts, MSc Niklas Schmedt, DrPH Priscilla Velentgas, PhD Csaba P. Kovesdy, MD
Site Logo
December 8th 2021

Medical Costs for Managing Chronic Kidney Disease and Related Complications in Patients With Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD Jinlin Song, PhD Elizabeth Faust, MBA, MPH Karen Yang, BA Yuxian Du, PhD Sheldon X. Kong, PhD Rakesh Singh, PhD
Site Logo
December 8th 2021

FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Michał Pochopień, MSc David Z. I. Cherney, MD, PhD Kerstin Folkerts, MSc Pierre Levy, PhD Aurélie Millier, PhD Stephen Morris, PhD Prabir Roy-Chaudhury, MD, PhD Sean D. Sullivan, PhD Paul Mernagh, MCom
Site Logo
December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

Linda F. Fried, MD, MPH Natalia Petruski-Ivleva, PhD Kerstin Folkerts, MSc Niklas Schmedt, DrPH Priscilla Velentgas, PhD Csaba P. Kovesdy, MD
Site Logo
December 8th 2021

eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Michał Pochopień, MSc David Z. I. Cherney, MD, PhD Kerstin Folkerts, MSc Pierre Levy, PhD Aurélie Millier, PhD Stephen Morris, PhD Prabir Roy-Chaudhury, MD, PhD Sean D. Sullivan, PhD Paul Mernagh, MCom
woman wearing a mask talking to a doctor over an iPad
December 6th 2021

Views on Telehealth vs In-Person Care Diverge Among Patients With CKD, Clinicians

Skylar Jeremias
Opinions on the effectiveness and usefulness of telehealth services varied among clinicians and older patients with chronic kidney disease (CKD), suggesting that new measures and training programs should be put in place to mitigate disparities and accessibility issues.
green and white pills and a syringe placed onto a paper with "kidney disease" written on it
December 4th 2021

Potential Link Found Between Vitamin D Therapy, Higher Hypercalcemia Risk in CKD

Skylar Jeremias
Patients with chronic kidney disease (CKD) and elevated levels of parathyroid hormone who are treated with active vitamin D therapy experienced significantly higher risks of hypercalcemia, investigators concluded in a meta-analysis.
image of a kidney surrounded by a superimposed over a clip art image of a cog
December 1st 2021

Nomogram Tool Can Predict Risk of CKD in Patients at High Risk of Developing Cardiovascular Disease

Skylar Jeremias
A tool utilizing 5 predictors was found to be reliable at identifying patients at a high risk of cardiovascular disease who were also at risk of developing chronic kidney disease (CKD), potentially allowing providers to implement prevention strategies sooner than ever before.
<123456789
...
13>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo